Nom du produit:1H-Pyrrolo[2,3-b]pyridin-5-ylmethanamine hydrochloride
IUPAC Name:1-{1H-pyrrolo[2,3-b]pyridin-5-yl}methanamine hydrochloride
Product Overview |
1H-Pyrrolo[2,3-b]pyridin-5-ylmethanamine hydrochloride, or PPMA-HCl, is an organic molecule that has been studied for its potential applications in scientific research. It is a derivative of pyridin-5-ylmethanamine, a compound that has been studied for its pharmacological properties, and is a member of the pyrrolo[2,3-b]pyridine family. PPMA-HCl has been studied for its ability to act as a neurotransmitter in the brain, as well as for its potential to act as a drug in the treatment of various diseases. |
Synthesis and Application |
PPMA-HCl can be synthesized through a variety of methods. The most common method is a condensation reaction between pyrrolo[2,3-b]pyridine and methylamine. This reaction is catalyzed by an acid, such as hydrochloric acid, and yields PPMA-HCl as the product. Other methods of synthesis include the reaction of pyrrolo[2,3-b]pyridine with a secondary amine, such as dimethylamine, and the reaction of pyrrolo[2,3-b]pyridine with an alkyl halide, such as ethyl chloride. PPMA-HCl has been studied for its potential applications in scientific research. It has been studied for its ability to act as a neurotransmitter in the brain, as well as for its potential to act as a drug in the treatment of various diseases. It has been studied for its potential to act as an agonist of the serotonin receptor 5-HT2A, and it has been studied for its potential to act as an antagonist of the dopamine receptor D2. It has also been studied for its potential to act as an inhibitor of the enzyme monoamine oxidase. |
Future Directions |
PPMA-HCl has potential future directions in scientific research. It has been studied for its potential to act as an agonist of the serotonin receptor 5-HT2A, and it has been studied for its potential to act as an antagonist of the dopamine receptor D2. It has also been studied for its potential to act as an inhibitor of the enzyme monoamine oxidase. It has also been studied for its potential to act as an antidepressant, an anxiolytic, and an antipsychotic. Additionally, PPMA-HCl has potential future directions in the development of novel drugs, as well as in the study of neurological disorders. |